Quantrx Biomedical Performance
| QTXBDelisted Stock | USD 0.0005 0.00 0.00% |
The company holds a Beta of 0.0, which implies not very significant fluctuations relative to the market. the returns on MARKET and Quantrx Biomedical are completely uncorrelated.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Quantrx Biomedical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Quantrx Biomedical is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
Quantrx |
Quantrx Biomedical Relative Risk vs. Return Landscape
If you would invest 0.05 in Quantrx Biomedical on November 8, 2025 and sell it today you would earn a total of 0.00 from holding Quantrx Biomedical or generate 0.0% return on investment over 90 days. Quantrx Biomedical is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Quantrx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Quantrx Biomedical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Quantrx Biomedical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Quantrx Biomedical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Quantrx Biomedical is not yet fully synchronised with the market data | |
| Quantrx Biomedical has some characteristics of a very speculative penny stock | |
| Quantrx Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (260.04 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quantrx Biomedical currently holds about 1.65 K in cash with (49.48 K) of positive cash flow from operations. | |
| Roughly 19.0% of the company outstanding shares are owned by corporate insiders |
Quantrx Biomedical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Quantrx Pink Sheet often depends not only on the future outlook of the current and potential Quantrx Biomedical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Quantrx Biomedical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 78.7 M | |
| Cash And Short Term Investments | 5950.00 |
Quantrx Biomedical Fundamentals Growth
Quantrx Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Quantrx Biomedical, and Quantrx Biomedical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Quantrx Pink Sheet performance.
| Return On Asset | -2.1 | |||
| Current Valuation | 3.21 M | |||
| Shares Outstanding | 78.7 M | |||
| Price To Earning | 0.62 X | |||
| EBITDA | (43.38 K) | |||
| Cash And Equivalents | 1.65 K | |||
| Total Debt | 2.77 M | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (49.48 K) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 5.95 K | |||
| Retained Earnings | (51.27 M) | |||
| Current Asset | 7 K | |||
| Current Liabilities | 1.76 M | |||
About Quantrx Biomedical Performance
By analyzing Quantrx Biomedical's fundamental ratios, stakeholders can gain valuable insights into Quantrx Biomedical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Quantrx Biomedical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Quantrx Biomedical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads and PAD based over-the-counter products in the United States. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon. Quantrx Biomedical is traded on OTC Exchange in the United States.Things to note about Quantrx Biomedical performance evaluation
Checking the ongoing alerts about Quantrx Biomedical for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Quantrx Biomedical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Quantrx Biomedical is not yet fully synchronised with the market data | |
| Quantrx Biomedical has some characteristics of a very speculative penny stock | |
| Quantrx Biomedical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (260.04 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Quantrx Biomedical currently holds about 1.65 K in cash with (49.48 K) of positive cash flow from operations. | |
| Roughly 19.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Quantrx Biomedical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Quantrx Biomedical's stock is overvalued or undervalued compared to its peers.
- Examining Quantrx Biomedical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Quantrx Biomedical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Quantrx Biomedical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Quantrx Biomedical's pink sheet. These opinions can provide insight into Quantrx Biomedical's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in median. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Quantrx Pink Sheet
If you are still planning to invest in Quantrx Biomedical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Quantrx Biomedical's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |